Biologics and Biosimilars Market - Outlook and Forecast 2021-2027
This report contains market size and forecasts of Biologics and Biosimilars in global, including the following market information:
- Global Biologics and Biosimilars Market Revenue, 2016-2021, 2022-2027, ($ millions)
- Global Biologics and Biosimilars Market Sales, 2016-2021, 2022-2027, (K Units)
- Global top five Biologics and Biosimilars companies in 2020 (%)
The global Biologics and Biosimilars market was valued at 187660 million in 2020 and is projected to reach US$ 226910 million by 2027, at a CAGR of 4.9% during the forecast period.
We surveyed the Biologics and Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/6561667/global-biologics-biosimilars-2021-2027-56
Total Market by Segment:
- Global Biologics and Biosimilars Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Biologics and Biosimilars Market Segment Percentages, By Type, 2020 (%):
- Monoclonal Antibodies
- Interferon
- Erythropoietin
- Insulin
- Vaccines
- Others
Global Biologics and Biosimilars Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Biologics and Biosimilars Market Segment Percentages, By Application, 2020 (%):
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Others
Global Biologics and Biosimilars Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Biologics and Biosimilars Market Segment Percentages, By Region and Country, 2020 (%):
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis:
The report also provides analysis of leading market participants including:
- Key companies Biologics and Biosimilars revenues in global market, 2016-2021 (Estimated), ($ millions)
- Key companies Biologics and Biosimilars revenues share in global market, 2020 (%)
- Key companies Biologics and Biosimilars sales in global market, 2016-2021 (Estimated), (K Units)
- Key companies Biologics and Biosimilars sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- Amgen
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- 3sbio
- Changchun High Tech
- CP Guojian
- Biotech
- Gelgen
- Innovent
- Dong Bao
- Ganlee
- United Laboratories
Reasons to Purchase Our Research Report:
- Analyzing the outlook of the market with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
- Regional and country-level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- Analyst support, along with the data support in excel format.
Get the Complete Report & TOC @ https://www.statsmarketresearch.com/global-biologics-biosimilars-2021-2027-56-6561667
